| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 1.5K | 8.0% |
| Total Income | 1.5K | 8.5% |
| Expenditure | 1.2K | 6.4% |
| PBT | 253.02 | 15.6% |
| Net Profit | 197.29 | 2.2% |
| OPM | 23.68% | 16.81pp |
| NPM | 13.13% | 0.81pp |
| EPS | 9.66 | 1.7% |
Narayana Hrudayalaya Reports 18.4% YoY Growth in Q4 FY25 Revenue, 22.2% YoY Growth in EBITDA
23 May 2025 · 23 May 2025, 07:54 pm
Summary
Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the fourth quarter (Q4 FY25) ended March 31, 2025. The company reported a YoY growth of 18.4% in Q4 FY25 consolidated operating revenue and a growth of 22.2% in EBITDA.
Key Highlights
- 1
Q4 FY25 Consolidated operating revenue at INR 14,754 Mns (YoY growth of 18.4%)
- 2
Q4 FY25 EBITDA at INR 3,846 Mns (YoY growth of 22.2%)
- 3
FY25 Consolidated operating revenue at INR 54,830 Mns (YoY growth of 12.1%)
- 4
FY25 EBITDA at INR 13,684 Mns (YoY growth of 11.9%)
- 5
India Revenue at INR 11,088 Mns for Q4 FY25 (YoY growth of 10.7%)
- 6
Cayman Revenue at INR 3,797 Mns for Q4 FY25 (YoY growth of 50.2%)
- 7
Consolidated EBITDA margin at 26.1% for Q4 FY25
- 8
PAT at INR 1,962 Mns for Q4 FY25 (YoY growth of 4.4%)
- 9
PAT % at 13.3% for Q4 FY25
- 10
Total Borrowings less Cash & Bank Balance and Investments at INR 5,330 Mns as on March 31, 2025
Management Comments
Dr. Emmanuel Rupert
The current financial year demonstrated strong performance across our units both domestic and international; we are pleased to report the highest-ever revenues and profitability margins on both quarterly as well as annual basis at the consolidated level... We thank the investor community for their faith in us and remain confident of delivering on expectations for the upcoming year.
Informational and educational content only. Not investment advice.